L8- Pulmonary Pathology IV Flashcards

(46 cards)

1
Q

NSIP:

(1) etiology
(2) prognosis in comparison to IPF/UIP
(3) age group affected
(4) Tx

A
(nonspecific insterstitial pneumonia)
1- unknown
2- better prognosis
3- younger people
4- steroids or immunomodulatory therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the histology of NSIP

A

(nonspecific insterstitial pneumonia)
-uniform fibrosing process (chicken-wire): i) cellular variant (lymphocyte infiltration), ii) fibrosing variant, iii) both

-lacks honeycomb change, fibroblast foci (in comparison to IPF/UIP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cryptogenic Organizing Pneumonia:

(1) alternate names
(2) etiology
(3) Sxs
(4) Radiographic findings
(5) Tx

A

1- BOOP (bronchiolitis obliterans organizing pneumonia)
2- unknown
3- cough, dyspnea
4- patchy peribronchial or subpleural consolidation
5- spontaneous recovery or with 6 mos steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the histology Cryptogenic Organizing Pneumonia

A

-Masson Bodies: polyploid plugs of loose fibroblastic tissue filling alveolar spaces

  • normal underlying parenchyma / alveolar architecture not destroyed
  • no interstitial fibrosis or honey combing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

(1) cause of Organizing Pneumonia

(2) cause of Cyptogenic Organizing Pneumonia

A

1- viral/bacterial pneumonia, inhaled chemicals/toxins, transplantation (lung, bone marrow), collagen vascular disease

2- unknown (or obscure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the histology of Organizing Pneumonia

A

(not cryptogenic)

  • interstitial fibrosis
  • honeycombing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AIP = (1)

  • (2) affected age group
  • (aggressive/benign) disease
  • follows (4) event or is apart of (5) event
  • (6) prognosis
A

(acute interstitial pneumonia)
1- Hamman-Rich Syndrome
2- older Pts, ~59 y/o
3- very aggressive
4- 2 wks post-URI
5- acute phase of IPF (interstitial pulmonary fibrosis)
6- significant mortality rate - survivors with recurrences and chronic conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AIP presents with (1) and (2) histologically, very similar to people who have (3)

A

(acute interstitial pneumonia)
1- diffuse alveolar damage
2- hyaline membranes
3- ARDS / DAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LIP = (1)

  • (2) interstitial changes
  • (3) associated conditions
  • (4) etiology / pathogenesis
  • (5) possible complication
A

1- lymphoid interstial pneumonia
2- interstitial expansion by groups/sheets of lymphoid cells
3- CT disease, autoimmune disease, HIV infection
4- idiopathic (possibly)
5- progression to lymphoma in small number of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Majority of interstitial lung diseases are related to (1), three examples include: (2)

A

1- smoking
2:
-DIP, desquamative interstitial pneumonia
-respiratory bronchiolitis associated interstitial lung disease
-Pulmonary Langerhans cell histiocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DIP = (1)

  • (2) affected group, age/sex
  • characterized by the presence of (3) in airspaces, seen in (4) patients
  • may also present with (5)
A
1- desquamative interstitial pneumonia
2- 50-60s, M=F
3- macrophages (filled alveolar space)
4- current/former smokers
5- emphysema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DIP = (1)

  • (2) clinical presentation
  • (3) pulmonary function test
  • (4) Tx
A

1- desquamative interstitial pneumonia
2- insidious onset of dry cough, dyspnea, clubbing of fingers
3- mild restrictive pattern (reduced volumes, inc/normal FEV1:FVC), moderately dec diffusion capacity
4- steroids, smoking cessaion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DIP = (1)

  • (2) histological results, hint- 3
  • (3) possible progression
A

1- desquamative interstitial pneumonia
2- alveolar macrophages (filled alveolar spaces), septal thickening, mild interstitial fibrosis
3- interstitial fibrosis (severe)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Respiratory bronchiolitis associated interstitial lung disease:

  • (1) are the 2 hallmark features
  • may also be present with (2)
  • (3) affected age group / smoker status
A

1- chronic inflammation, peribronchiolar fibrosis
2- centrilobar emphysema
3- 50-60 y/o /// >30 pack years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Respiratory bronchiolitis associated insterstitial lung disease:

  • (1) hallmark histological feature
  • (2) clinical presentation
  • (3) Tx
A

1- intraluminal pigmented macrophage (intracellular carbon) accumulation in 1st/2nd order respiratory bronchioles
2- mild disease, gradual onset of dyspnea, cough
3- steroids, smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PAP = (1)
-(2) is the defect => (3) dysfunction and issue

Causes: (4), (5), (6)

A

1- pulmonary alveolar proteinosis (rare disease)
2- GM-CSF defect
3- pulmonary macrophage dysfunction => surfactant accumulation in alveolar/bronchiolar spaces

4- Autoimmune (90% cases): adults
5- Secondary: many disorders impairing macrophage maturation / activity
6- Congenital/hereditary: rare, GM-CSF related mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PAP = (1)

  • (2) clinical presentation
  • (3) Tx (hint- 2)
A

1- pulmonary alveolar proteinosis (rare disease)

2- very productive (gelatinous) cough, progressive dyspnea / cyanosis / respiratory failure [or a benign course with resolution]

3- pulmonary lavage (therapeutic) + GM-CSF replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sarcoidosis:

  • (1) affected organs
  • (2) is the hallmark feature seen in affected organs
  • (3) etiology / pathogenesis
  • highest prevalence in (4) patients
A

1- multiple organs / tissues
2- non-caseating / non-necrotizing granulomatous inflammation
3- unknown- evidence it involves Immune Response via Th cells to specific Ag (possible genetic pre-disposition)
4- young adults (<40 y/o) and smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sarcoidosis results from a (1) hypersensitivity reaction to (2), driven by (3) cells

A

1- type IV hypersensitivity reaction
2- unknown Ag
3- Th cells (CD4+)

20
Q

Sarcoidosis clinical presentation:

  • (1) is an important feature related to its presentation
  • (2) lung Sxs
  • (3) constitutional Sxs
  • (4) other organs involved –> (5) organs may have severe impairment
A

1- variable presentation, asymptomatic to serious presentation
2- (90% cases involve lungs) gradual respiratory Sx development: dry cough, SOB/dyspnea, vague discomfort)
3- fever, weight loss, fatigue, night sweats
4- skin (erythema nodosum), eyes (lacrimal glands - sicca syndrome), parotid glands (bilateral parotitis), spleen, liver, bone marrow
5- CNS, cardiac system, ocular system, skin

21
Q

Sarcoidosis:

1) lab results
(2) CXR results (note hallmark feature

A

1- hypercalcemia + its resulting Sxs; elevated ACE (60% cases)

2- bilateral hilar lymadenopathy, +/- parenchymal infiltrates or fibrosis

22
Q

Sarcoidosis Histology:

  • (1) hallmark feature
  • (2) progressive feature
  • (3) rare feature
  • (4)/(5) are the special histological and other hallmark features
A

1- non-necrotizing epithelioid granuloma w/ lymphangitic distribution
2- hyalinized scar (via collagen replacing granuloma)
3- (5-15%) progression to interstitial fibrosis and honeycombing

4- Schaumann bodies (Ca-protein concretions)
5- Astroid bodies (giant cell stellate inclusions)

23
Q

define:

(1) Schaumann bodies

(2) Asteroid bodies

A

(for Sarcoidosis Histo)
1- laminated concretions of Ca and protein

2- stellate inclusions in giant cells

24
Q

Sarcoidosis Tx

  • 65-70% result in (1)
  • 20% result in (2)
  • 5-15% result in (3)

-(4) can occur post-lung transplantation

A

(Note- remission is spontaneous or with therapy)
1- recovery
2- permanent lung dysfunction
3- progressive fibrosis and cor pulmonale
4- sarcoidosis can reocur in 35% of Pts

25
HP / EAA = (1) - (2) is the general pathogenesis - (3), (4), (5) are possible causes
1- hypersensitivity pneumonia / extrinsic allergic alveolitis 2- inhaled Ag (organic Ag) => granulomatous interstitial pneumonitis (= EAA) --> restrictive lung disease (occupational exposures) 3- Farmer's lung: moldy hay from thermophilic bacteria 4- Silo filler's disease: plant material gas inhalation (oxides of nitrogen) 5- Byssinosis: cotten, linen, hemp, textile factory worker
26
HP / EAA = (1) - general pathogenesis (2) - (3) first exposure - (4) second exposure - (5) chronic exposure
1- hypersensitivity pneumonia / extrinsic allergic alveolitis 2- Type III hypersensitivity reaction; immunologic mediated response to extrinsic Ag 3- => IgG in serum 4- Ig-Ag complex --> interstitial inflammatory response 5- granuloma formation via Type IV hypersensitivity response
27
HP / EAA = (1) | -histopathology = (2)
1- hypersensitivity pneumonia / extrinsic allergic alveolitis 2- airway centered process with chronic inflammatory infiltrate, organizing pneumonia, poorly formed non-necrotizing granulomas with giant cells
28
define Pneumonconiosis + list 3 most common conditions
- non-neoplastic lung diseases secondary to inhalation of mineral dusts (occupational) - asbestosis, silicosis, CWP (coal workers pneumoconiosis)
29
define and list the causes of the 2 types of Pneumonconiosis
Fibrogenic: asbestos, silica Inert of Weakly Fibrogenic: C, Fe oxides
30
Pneumonconiosis pathogenesis includes the participation of (1) cells that will release and secrete (2) and (3) in order to get (4) overall in the lung
1- macrophages 2- lysosomal enzymes / free radicals --> tissue injury + reparative response 3- IL-1 + GFs --> fibroblast proliferation 4- 2/3 ---> fibrosis
31
Asbestosis: - (1) define asbestos - (2) high risk occupations - (3) associated lung developments
1- family of hydrated silicates, fibrous geometry / fibrous silicates, proinflammatory 2- mining, milling, insulation, construction, demolition 3- parenchymal interstitial fibrosis (asbestosis), localized/dissue fibrous plaques, pleural effusions, lung Ca, malignant pleural / peritoneal mesothelioma and laryngeal CA
32
Asbestosis: exposure of asebestos fibers to (1) leads to its 'uptake' by (2) cells. (2) activation will initiate a (3) reaction and long-term exposure will eventually lead to (4) because of chronic (3) reaction.
1- deep lung tissue 2- phagcytosis via alveolar macrophages 3- inflammatory (inflammasome --> CK release) 4- diffuse interstitial fibrosis
33
Asbestosis in the lung histologically is exhibited by....
Asbestos Bodies: golden-brown, beaded rods, translucent center -consists of asbestos fiber w/ Fe containing proteinaceous material
34
list the associated lung lesions from asbestos
- asbestos body deposition - peribronchilar fibrosis - diffuse interstitial fibrosis - lung Ca
35
list the pleural associated lung lesions from asbestos
- Plaques | - Mesothelioma***
36
pleural plaques from asbestos is usually made up of (1), but (2) are absent and it is usually found in (3) area
1- dense collagen, calcification 2- asbestos bodies 3- over domes of diaphragm
37
list the clinical presentation of Asbestosis
(similar to most other diffuse interstitial lung diseases) - cough, dyspnea - possible progression to respiratory failure and cor pulmonale
38
Silicosis: (1) definition (2) risks (3) associated materials
1- inhalation of proinflammatory crystalline silicon dioxide (silica) 2- mining, demolition, stonecutting, sandblasting, grinding, foundry work, ceramics 3- silica (amorphous / crystalline forms), Quartz, cristobalite / tridymite (crystalline form is most fibrogenic/toxic)
39
In silicosis, the inhaled material interacts with (1) and (2) leading to activation of (3) and release of (4). There is an increased risk for (5) because of (6).
1- epithelial cells 2- alveolar macrophages 3- inflammasome 4- IL-1, IL-8 + TNF, fibronectin, lipid mediators, free radicals, IL-18 5- pulmonary Tb 6- crystalline silica inhibits pulmonary macrophages ability to phagocytose bacteria
40
Silicosis: - (1) and (2) are the main gross morphological changes - (3) is the main histological change, with (4) seen under polarized light
1- collagenous scar/nodule: hilar lymph nodes and upper lung fields 2- Eggshell calcification: calcified sheet in lymph nodes (radiographically seen) 3- central area with whorled collagen fibers + dust-laiden macrophages 4- weakly birefringent (polarized microscopy)
41
Silicosis: - (slow/fast) progression - (2) in early stages, only (3) is noticeable - (4) Sx in later stages - (5) complications in later stages (hint- 4) - (6) important correlation possibly related to (5)
1- slow progression 2- asymptomatic 3- on CXR: fine nodularity in upper zones of lung field 4- SOB 5- progressive massive fibrosis, pulmonary HTN, cor pulmonale, inc susceptibility to Tb 6- inc risk of Lung CA
42
CWP = (1) - (2) definition - (3) particle description - (4) typical presentation (early stages)
1- coal workers pneumoconiosis 2- inhalation of coal particles and other admixed forms of dust 3- mostly carbon with other silica/minerals and organic/metallic compounds 4- asymptomatic
43
list the 3 possible morphological changes seen in CWP
(coal workers' pneumoconiosis) - Anthracosis - Simple CWP - Complicated CWP
44
describe anthracosis (histologically + clinical presentation
(seen in CWP) -accumulation of carbon pigment from alveolar/interstitial macrophage phagocytosis along CT in lymphatic regions (lymph nodes) -asymptomatic (no appreciable pathologic changes)
45
describe simple CWP (histologically + clinical presentation)
- macule 1-2 mm + nodules - aggregation of dust-laden macrophages - minimal or absent fibrosis - associated with centrilobar emphysema (smokers) -little to no pulmonary dysfunction
46
describe complicated CWP (histologically + clinical presentation)
(progressive massive fibrosis) -coalescence of nodules --> fibrinous scars; appear blackened and >1cm - impaired pulmonary function (restrictive) - <10% of simple CWP progress to this stage